Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
为什么Keysight Technologies股票交易价上涨约11%,这里有20只股票在盘前交易
Shares of Keysight Technologies, Inc. (NYSE:KEYS) rose sharply in today's pre-market trading after the company reported stronger-than-expected results for its third quarter.
美股盘前,Keysight Technologies股票(NYSE:KEYS)大幅上涨,因该公司发布了强于预期的第三季度财报。
The company said it sees fourth-quarter earnings between $1.53 and $1.59 per share, versus the $1.54 estimate, and revenue in a range of $1.245 billion to $1.265 billion, versus the $1.25 billion estimate.
该公司表示,预计第四季度每股收益在1.53至1.59美元之间,略高于1.54美元的预估值,营业收入区间为12.45亿至12.65亿美元,略高于12.5亿美元的预估值。
Keysight shares jumped 11.1% to $154.01 in pre-market trading.
Keysight股票在美股盘前交易中上涨11.1%,至154.01美元。
Here are some other stocks moving in pre-market trading.
以下是其他在美股盘前交易中受到影响的股票。
Gainers
涨幅
- Revelation Biosciences, Inc. (NASDAQ:REVB) rose 170.1% to $2.81 in today's pre-market trading after jumping over 19% on Tuesday.
- Anew Medical, Inc. (NASDAQ:WENA) gained 68% to $1.73 in pre-market trading. ANEW MEDICAL acquired license to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke.
- Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) gained 44.8% to $0.4373 in pre-market trading.
- BigBear.ai Holdings, Inc. (NASDAQ:BBAI) shares rose 33.1% to $1.76 in pre-market trading after the company received an award as a subcontractor to Concept Solutions.
- Sintx Technologies, Inc. (NASDAQ:SINT) gained 28.2% to $5.54 in pre-market trading after declining around 9% on Tuesday.
- Oblong, Inc. (NASDAQ:OBLG) gained 25.3% to $0.1338 in pre-market trading after declining 5% on Tuesday.
- Gaxos.ai Inc. (NASDAQ:GXAI) gained 21.1% to $3.04 in pre-market trading after gaining 9% on Tuesday.
- Azitra, Inc. (NYSE:AZTR) gained 15.3% to $0.7330 in pre-market trading after the company announced that it screened the first patient in its Phase 1b clinical trial evaluating ATR-12 for the treatment of Netherton syndrome.
- Invivyd Inc (NASDAQ:IVVD) shares gained 14.7% to $0.99 in pre-market trading.
- 美股盘前,Revelation Biosciences股票(纳斯达克:REVB)上涨170.1%,至2.81美元,此前该股票周二上涨了超过19%。
- 美股盘前,Anew Medical股票(纳斯达克:WENA)上涨68%,至1.73美元。Anew Medical从Transfertech Sherbrooke获得了无针式干粉自动注射器的许可证。
- 美股盘前,Galmed Pharmaceuticals股票(纳斯达克:GLMD)上涨44.8%,至0.4373美元。
- 在InMed Pharmaceuticals (纳斯达克:BBAI)获得概念解决方案的分包商奖项后,股票上涨了33.1%,达到了$1.76的盘前交易价格。
- 在周二下跌约9%后,Sintx Technologies (纳斯达克:SINT)在盘前交易中上涨了28.2%,达到了$5.54的价格。
- 在周二下跌5%后,Oblong (纳斯达克:OBLG)在盘前交易中上涨了25.3%,达到了$0.1338的价格。
- 在周二上涨了9%后,Gaxos.ai (纳斯达克:GXAI)在盘前交易中上涨了21.1%,达到了$3.04的价格。
- Azitra (纽交所:AZTR)在盘前交易中上涨了15.3%,达到了$0.7330的价格,原因是公司宣布启动了针对Netherton综合征治疗的ATR-12的第10亿阶段临床试验,并已筛选了首位患者。
- Invivyd (纳斯达克:IVVD)股票在盘前交易中上涨了14.7%,达到了$0.99的价格。
Losers
跌幅
- Eyenovia, Inc. (NASDAQ:EYEN) shares fell 34.1% to $0.4480 in pre-market trading after the company announced a proposed public offering.
- Santech Holdings Limited (NASDAQ:STEC) shares declined 33.6% to $0.2850 in pre-market trading after jumping 109% on Tuesday.
- Aadi Bioscience, Inc. (NASDAQ:AADI) declined 27.2% to $1.18 in pre-market trading after the company issued PRECISION1 trial and corporate updates.
- Mynaric AG (NASDAQ:MYNA) fell 24.6% to $1.38 in today's pre-market trading. Mynaric shares dipped 56% on Tuesday after the company cut its FY24 revenue guidance.
- Applied DNA Sciences, Inc. (NASDAQ:APDN) shares fell 24.1% to $1.17 in pre-market trading after declining 14% on Tuesday.
- InMed Pharmaceuticals Inc. (NASDAQ:INM) fell 23.2% to $0.3310 in pre-market trading. InMed Pharmaceuticals shares surged 191% on Tuesday after the company announced that INM-901 will be used in its development programs for Alzheimer's Disease.
- Treasure Global Inc. (NASDAQ:TGL) fell 17.8% to $1.15 in pre-market trading after jumping 141% on Tuesday.
- Heramba Electric plc (NASDAQ:PITA) shares dipped 16.4% to $2.33 in pre-market trading after jumping around 33% on Tuesday.
- Allbirds Inc (NASDAQ:BIRD) shares declined 16.2% to $0.61 in pre-market trading.
- Allego N.V. (NYSE:ALLG) shares fell 7.8% to $1.77 in pre-market trading after jumping over 82% on Tuesday.
- 在公司提出拟议的公开发行后,Eyenovia (纳斯达克:EYEN)股票在盘前交易中下跌了34.1%,达到了$0.4480的价格。
- Santech Holdings Limited(纳斯达克:STEC)股票在盘前交易中下跌33.6%,至0.2850美元,在周二上涨109%后。
- Aadi Bioscience, Inc.(纳斯达克:AADI)股票在盘前交易中下跌27.2%,至1.18美元,此前公司发布了PRECISION1试验和企业更新。
- Mynaric AG(纳斯达克:MYNA)股票在今天的盘前交易中下跌24.6%,至1.38美元。在公司下调2024财年营业收入预期后,Mynaric股价在周二下跌了56%。
- Applied DNA Sciences, Inc.(纳斯达克:APDN)股票在盘前交易中下跌24.1%,至1.17美元,周二下跌了14%。
- InMed Pharmaceuticals Inc.(纳斯达克:INM)股票在盘前交易中下跌23.2%,至0.3310美元。在公司宣布INm-901将用于其阿尔茨海默病发展项目后,InMed Pharmaceuticals股价在周二大涨191%。
- Treasure Global Inc.(纳斯达克:TGL)股票在盘前交易中下跌17.8%,至1.15美元,在周二上涨141%后。
- Heramba Electric plc(纳斯达克:PITA)股票在盘前交易中下跌16.4%,至2.33美元,周二上涨约33%。
- Allbirds Inc(纳斯达克:BIRD)股票在盘前交易中下跌16.2%,至0.61美元。
- Allego N.V.(纽交所代码:ALLG)股价在盘前交易中下跌7.8%,至1.77美元,周二上涨逾82%。
Now Read This:
现在阅读这个:
- Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter
- 本季度可能挽救您投资组合的前三科技股